Amphastar Pharmaceuticals, Inc (29A) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,32%	1 100,57	−3,53	−0,32%	—	1 104,10	1 103,92	1 108,75	1 097,16	—	—
SIXC Communications SIXC Communications	SIXC +0,16%	605,15	+0,99	+0,16%	—	604,16	604,16	610,19	604,12	—	—
SIXE Energy SIXE Energy	SIXE −0,22%	1 195,19	−2,62	−0,22%	—	1 197,81	1 200,58	1 213,07	1 192,02	—	—
SIXI Industrials SIXI Industrials	SIXI −0,03%	1 739,91	−0,50	−0,03%	—	1 740,41	1 739,55	1 750,27	1 730,60	—	—
SIXM Financials SIXM Financials	SIXM +0,65%	638,56	+4,12	+0,65%	—	634,44	633,13	639,87	633,01	—	—
SIXR Staples SIXR Staples	SIXR −1,11%	831,57	−9,33	−1,11%	—	840,90	839,53	841,73	831,10	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,82%	213,36	−1,77	−0,82%	—	215,13	215,13	215,85	213,24	—	—
SIXT Technology SIXT Technology	SIXT +0,17%	3 234,18	+5,47	+0,17%	—	3 228,71	3 225,62	3 235,43	3 198,95	—	—
SIXU Utilities SIXU Utilities	SIXU −0,02%	935,65	−0,22	−0,02%	—	935,87	938,37	942,00	935,65	—	—
SIXV Health care SIXV Health care	SIXV −0,54%	1 449,26	−7,86	−0,54%	—	1 457,12	1 452,74	1 466,88	1 449,18	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,72%	2 382,45	−17,39	−0,72%	—	2 399,84	2 389,71	2 394,61	2 371,22	—	—

29A:FRA

Amphastar Pharmaceuticals, Inc

17,98 €

+1,50%

(+0,27) 1 D

28. apr., 08:04:07 GMT+2 · EUR

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for 29A …

Åpne

17,98 €

Høy

17,98 €

Lav

17,98 €

Markedsverdi

964,18 mill.

Snittvolum

0,00

Volum

0,00

52 u høy

25,96 €

52 u lav

15,26 €

Antall ansatte

Relaterte aksjer

Nyhetssaker

Fra kilder på nettet

MarketBeat

for 2 minutter siden

Himax Technologies (NASDAQ:HIMX) Reaches New 12-Month High - Should You Buy?

Simply Wall Street

for 5 minutter siden

Why Aeluma (ALMU) Is Up 19.9% After New NASA Award And Defense Tech Conference Spotlight

Finimize

for 25 minutter siden

AI Anxiety Is Testing The S&P 500’S Long-Term Valuations

Simply Wall Street

for 1 time siden

Will InterDigital’s (IDCC) SMPTE-Based HDR Streaming Workflow Shift Its Core Licensing-Led Narrative?

Profil

Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products. One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around $20 to $40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally. In March 2018, the company won a patent infringement lawsuit brought against it by Momenta Pharmaceuticals and Sandoz Inc in an ongoing antitrust case. In April 2023, Amphastar Pharmaceuticals bought Baqsimi from Eli Lilly in a deal worth over $1bn. Wikipedia

Om Amphastar Pharmaceuticals, Inc

Administrerende direktør-

Ansatte1,98k

Grunnlagt1996

HovedkontorRancho Cucamonga, California, USA

Sektor-

Nettstedamphastar.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	170,53 mill.	174,41 mill.	191,84 mill.	183,10 mill.
Varekostnad	85,28 mill.	87,92 mill.	93,19 mill.	97,44 mill.
Direkte driftskostnader	85,28 mill.	87,92 mill.	93,19 mill.	97,44 mill.
Utgifter til forskning og utvikling	20,10 mill.	20,08 mill.	22,35 mill.	23,31 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	27,86 mill.	24,23 mill.	27,87 mill.	26,75 mill.
Driftskostnader	47,96 mill.	44,31 mill.	50,23 mill.	50,06 mill.
Totale driftskostnader	133,24 mill.	132,23 mill.	143,42 mill.	147,50 mill.
Driftsinntekter	37,29 mill.	42,18 mill.	48,42 mill.	35,61 mill.
Andre ikke-operasjonelle inntekter	666,00k	−189,00k	231,00k	215,00k
EBT inkludert uvanlige elementer	30,86 mill.	39,34 mill.	21,51 mill.	31,91 mill.
EBT uten uvanlige elementer	30,86 mill.	39,34 mill.	44,61 mill.	31,91 mill.
Kostnad for inntektsskatt	5,58 mill.	8,30 mill.	4,16 mill.	7,48 mill.
Faktisk avgiftssats	18,07 %	21,11 %	19,35 %	23,45 %
Andre driftskostnader	-	-	-	-
Nettoinntekt	25,28 mill.	31,03 mill.	17,35 mill.	24,43 mill.
Netto fortjenestemargin	14,83 %	17,79 %	9,04 %	13,34 %
Resultat per aksje	0,74	0,85	0,93	0,73
Rente- og investeringsinntekter	2,09 mill.	1,92 mill.	2,25 mill.	2,42 mill.
Rentekostnader	−9,19 mill.	−4,58 mill.	−6,28 mill.	−6,33 mill.
Netto rentekostnader	−7,10 mill.	−2,66 mill.	−4,04 mill.	−3,91 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	50,90 mill.	56,80 mill.	62,55 mill.	49,95 mill.
Gevinst eller tap ved salg av eiendeler	2,00k	30,00k	1,00k	6,00k

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning